Skip to main content
SpringerLink
Log in

Pathology of Retinoblastoma: An Update

  • Chapter
  • First Online:
Ocular Tumors

Abstract

Retinoblastoma (RB) is 3% of all childhood cancer. It is the first tumor suppressor gene decoded in human being. Pathology of RB is important and a lot of advances were made in the past decade on this childhood cancer. Tumor genetics on RB and understanding the histopathological high-risk factors were highlighted here. New rosette of retinoblastoma by the author and its molecular interpretations along with RB seeds were discussed extensively. This review chapter highlights newer molecular pathology scope with potential biomarkers involving RB.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel IJ, Boyd NW III. Presenting signs of retinoblastoma. J Pediatr. 1998;132(3 Pt 1):505–8.

    Article  CAS  Google Scholar 

  2. Abramson DH. Retinoblastoma incidence in the United States. Arch Ophthalmol. 1990;108:1514.

    Article  CAS  Google Scholar 

  3. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93(9):1129–31.

    Article  Google Scholar 

  4. Vemuganti G, Honavar S, John R. Clinicopathological profile of retinoblastoma patients in Asian Indians. Invest Ophthalmol Vis Sci. 2000;41(S):790.

    Google Scholar 

  5. Eagle RC Jr. Eye pathology: an atlas and text. 2nd ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2011.

    Google Scholar 

  6. Shields CL, Shields JA, Shah P. Retinoblastoma in older children. Ophthalmology. 1991;98:395–9.

    Article  CAS  Google Scholar 

  7. Singh AD, Murphee AL, Damato BE. Clinical ophthalmic oncology. Retinoblastoma. 2nd ed: Springer; 2015.

    Google Scholar 

  8. Singh L, Kashyap S. Update on pathology of retinoblastoma. Int J Ophthalmol. 2018;11(12):2011–6.

    PubMed  PubMed Central  Google Scholar 

  9. Ramasubramanian A, Shields CL. Retinoblastoma. 1st ed. New Delhi: Jaypee Brothers Medical Publishers; 2012.

    Google Scholar 

  10. Arora RS, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.

    Article  CAS  Google Scholar 

  11. Murphree AL, Samuel MA, Harbour JW, Mansfeld NC. Retinoblastoma. In: Ryan SJ, Schachat AP, editors. Retina. 4th ed. Philadelphia: Mosby; 2006. p. 558–607.

    Google Scholar 

  12. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunklel IJ, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47:801–5.

    Article  Google Scholar 

  13. Benedict WF, Muephree AL, Banerjee A, Spina CA, Sparkes MC, Sparkes RS. Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science. 1983;219:973–5.

    Article  CAS  Google Scholar 

  14. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820–3.

    Article  Google Scholar 

  15. Athavale V, Khetan V. Knudson to embryo selection: a story of the genetics of retinoblastoma. Taiwan J Ophthalmol. 2018;8:196–204.

    Article  Google Scholar 

  16. Soliman SE, Dimaras H, Khetan V, Gardinar JA, Chan HSL, Heon E, et al. Prenatal versus postnatal screening for familial retinoblastoma. Ophthalmology. 2016;123(12):2610–7.

    Article  Google Scholar 

  17. Murphree AL. Molecular genetics of retinoblastoma. Ophthalmol Clin N Am. 1995;8:155–66.

    Google Scholar 

  18. Eagle RC Jr. High-risk features and tumour differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133(8):1203–9.

    PubMed  Google Scholar 

  19. Sastre X, Chantada GL, Doz F, Wilson MW, de Davila MT, Rodríguez-Galindo C, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133(8):1199–202.

    PubMed  Google Scholar 

  20. Das D, Deka P, Bhattacharjee K, Barman MJ, Bhattacharjee H, Mishra D, et al. Molecular pathologic interpretation of new retinoblastoma rosettes. Indian J Ophthalmol. 2017;65:764–7.

    Article  Google Scholar 

  21. Das D, Bhattacharjee H, Deka A, Deka P, Serasiya S, Bhattacharjee K, Das JK, et al. Immunohistochemistry on pattern of ocular & adnexal tumours in a tertiary eye care centre of Northeast India. Indian J Med Res. 2018;147:41–5.

    Article  CAS  Google Scholar 

  22. Das D, Bhattacharjee K, Barthakur SS, Tahiliani PS, Deka P, Bhattacharjee H, et al. A new rosette in retinoblastoma. Indian J Ophthalmol. 2014;62:638–41.

    Article  Google Scholar 

  23. Biswas J, Das D, Krishnakumar S, Shanmugam MP. Hisopathological analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabisums. 2003;40:1–3.

    Google Scholar 

  24. Tso MO, Fine BS, Zimmerman LE. The Flexner-Wintersteiner rosettes in retinoblastoma. Arch Pathol. 1969;88:664–71.

    CAS  Google Scholar 

  25. Tso MO, Fine BS, Zimmerman LE. The nature of retinoblastoma. II. Photoreceptor differentiation: an electron microscopic study. Am J Ophthalmol. 1970;69:350–9.

    Article  CAS  Google Scholar 

  26. Kashyap S, Meel R, Pushker N, Sen S, Bakhshi S, Sreenivas V, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012;58(3):356–61.

    Article  Google Scholar 

  27. Honavar SG, Singh AD, Shields CL, Meadows AT, Demirci H, Cater J, et al. Post-enucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120(7):923–31.

    Article  Google Scholar 

  28. Kaliki S, Shields CL, Shah SU, Eagle RC Jr, Shields JA, Leahey A. Post-enucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol. 2011;129(11):1422–7.

    Article  CAS  Google Scholar 

  29. Samuels BL, Bitran JD. High dose intravenous melphalan: a review. J Clin Oncol. 1995;13:1786–99.

    Article  CAS  Google Scholar 

  30. Eagle RC, Shields CL, Bianciotto C, Jabbour P, Shields JA. Histopathologic observation after intra-arterial chemotherapy for retinoblastoma. Arch Ophthalmol. 2011;121:1416–21.

    Article  Google Scholar 

  31. Munier FL. Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013. Ophthalmic Genet. 2014;35(4):193–207.

    Article  Google Scholar 

  32. Singh L, Pushker N, Sen S, Singh MK, Bakhshi S, Chawla B, Kashyap S. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters. Br J Ophthalmol. 2015;99:457–63.

    Article  Google Scholar 

  33. Das D, Bhattacharjree K, Tahiliani PS, Bhattacharyya P, Barman MJ, et al. Efferocytosis in retinoblastoma. J Cancer Ther. 2013;4:1443–7.

    Article  Google Scholar 

  34. Sangeetha M, Deepa PR, Rishi P, Khetan V, Krishnakumar S. Gobal gene deregulations in FASAN silenced retinoblastoma cancer cells: molecular and clinic-pathological correlations. J Cell Biochem. 2015;116(11):2676–94.

    Article  CAS  Google Scholar 

  35. Batra A, Kashyap S, Singh L, Bakhshi S. Expression of FOXO3a and correlation with histopathologic features in retinoblastoma. Appl Immunohistochem Mol Morphol. 2017;25(2):95–9.

    Article  CAS  Google Scholar 

  36. Batra A, Kashyap S, Singh L, Bakhshi S. Sirtunil expression and correlation with histopathological features in retinoblastoma. Ocul Oncol Pathol. 2015;2(2):86–90.

    Article  Google Scholar 

  37. Gerrish A, Stone E, Ainsworth JR, Jenkinson H, Maureen MC, Hitchcott C, et al. Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour. Br J Ophthalmol. 2019;103:721–4.

    Article  Google Scholar 

  38. Shields CL, Shields JA, Donoso LA. Clinical genetics of retinoblastoma. Int Ophthalmol Clin. 1993;33:67–76.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

  • Dr. Kasturi Bhattacharjee MS, DNB, FRCS; Dr. Manab Jyoti Barman DO, DNB; Dr. Bidhan Chandra Das MD; Dr. Jayanta Kumar Das DO, DNB, PhD; Dr. Ganesh Chandra Kuri MS, Dr. Saurabh Deshmukh DNB, Mr. Apurba Deka MSc and Miss Bhaswati Talukdar, Sri Sankaradeva Nethralaya, Guwahati, Assam, India.

  • Kanchi Sankara Health and Educational Foundation, Guwahati, Assam, India.

Financial Disclosure

Nil.

Funding

Nil.

Author information

Authors and Affiliations

  1. Department of Ocular Pathology, Uveitis and Neuro-ophthalmology Services, Sri Sankaradeva Nethralaya, Guwahati, Assam, India

    Dipankar Das

  2. Sri Sankaradeva Nethralaya, Guwahati, Assam, India

    Panna Deka & Harsha Bhattacharjee

  3. Department of Ocular Pathology and Uveitis, Sankara Nethralaya, Chennai, Tamil Nadu, India

    Jyotirmay Biswas

Authors
  1. Dipankar Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Panna Deka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jyotirmay Biswas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Harsha Bhattacharjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Former Professor and Head, Department of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

    H. V. Nema

  2. Professor, Department of Ophthalmology, Sri Aurobindo Medical College & PG Institute, Indore, India

    Nitin Nema

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Das, D., Deka, P., Biswas, J., Bhattacharjee, H. (2021). Pathology of Retinoblastoma: An Update. In: Nema, H.V., Nema, N. (eds) Ocular Tumors. Springer, Singapore. https://doi.org/10.1007/978-981-15-8384-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-8384-1_4

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-8383-4

  • Online ISBN: 978-981-15-8384-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation